486 related articles for article (PubMed ID: 32281218)
1. Sitagliptin ameliorates renal tubular injury in diabetic kidney disease via STAT3-dependent mitochondrial homeostasis through SDF-1α/CXCR4 pathway.
Zhang Q; He L; Dong Y; Fei Y; Wen J; Li X; Guan J; Liu F; Zhou T; Li Z; Fan Y; Wang N
FASEB J; 2020 Jun; 34(6):7500-7519. PubMed ID: 32281218
[TBL] [Abstract][Full Text] [Related]
2. Extracellular Ubiquitin(1-76) and Ubiquitin(1-74) Regulate Cardiac Fibroblast Proliferation.
Jackson EK; Mi E; Ritov VB; Gillespie DG
Hypertension; 2018 Oct; 72(4):909-917. PubMed ID: 30354710
[TBL] [Abstract][Full Text] [Related]
3. Dipeptidyl Peptidase-4 Inhibitor Increases Vascular Leakage in Retina through VE-cadherin Phosphorylation.
Lee CS; Kim YG; Cho HJ; Park J; Jeong H; Lee SE; Lee SP; Kang HJ; Kim HS
Sci Rep; 2016 Jul; 6():29393. PubMed ID: 27381080
[TBL] [Abstract][Full Text] [Related]
4. The effect of DPP-4 inhibition to improve functional outcome after stroke is mediated by the SDF-1α/CXCR4 pathway.
Chiazza F; Tammen H; Pintana H; Lietzau G; Collino M; Nyström T; Klein T; Darsalia V; Patrone C
Cardiovasc Diabetol; 2018 May; 17(1):60. PubMed ID: 29776406
[TBL] [Abstract][Full Text] [Related]
5. Stromal cell-derived factor-1 is upregulated by dipeptidyl peptidase-4 inhibition and has protective roles in progressive diabetic nephropathy.
Takashima S; Fujita H; Fujishima H; Shimizu T; Sato T; Morii T; Tsukiyama K; Narita T; Takahashi T; Drucker DJ; Seino Y; Yamada Y
Kidney Int; 2016 Oct; 90(4):783-96. PubMed ID: 27475229
[TBL] [Abstract][Full Text] [Related]
6. Sitagliptin and shock wave-supported peripheral blood derived endothelial progenitor cell therapy effectively preserves residual renal function in chronic kidney disease in rat-role of dipeptidyl peptidase 4 inhibition.
Sung PH; Chen KH; Li YC; Chiang JY; Lee MS; Yip HK
Biomed Pharmacother; 2019 Mar; 111():1088-1102. PubMed ID: 30841422
[TBL] [Abstract][Full Text] [Related]
7. Rap1 ameliorates renal tubular injury in diabetic nephropathy.
Xiao L; Zhu X; Yang S; Liu F; Zhou Z; Zhan M; Xie P; Zhang D; Li J; Song P; Kanwar YS; Sun L
Diabetes; 2014 Apr; 63(4):1366-80. PubMed ID: 24353183
[TBL] [Abstract][Full Text] [Related]
8. The mitochondria-targeted antioxidant MitoQ ameliorated tubular injury mediated by mitophagy in diabetic kidney disease via Nrf2/PINK1.
Xiao L; Xu X; Zhang F; Wang M; Xu Y; Tang D; Wang J; Qin Y; Liu Y; Tang C; He L; Greka A; Zhou Z; Liu F; Dong Z; Sun L
Redox Biol; 2017 Apr; 11():297-311. PubMed ID: 28033563
[TBL] [Abstract][Full Text] [Related]
9. The oral dipeptidyl peptidase-4 inhibitor sitagliptin increases circulating endothelial progenitor cells in patients with type 2 diabetes: possible role of stromal-derived factor-1alpha.
Fadini GP; Boscaro E; Albiero M; Menegazzo L; Frison V; de Kreutzenberg S; Agostini C; Tiengo A; Avogaro A
Diabetes Care; 2010 Jul; 33(7):1607-9. PubMed ID: 20357375
[TBL] [Abstract][Full Text] [Related]
10. Modulation of Prostanoids Profile and Counter-Regulation of SDF-1α/CXCR4 and VIP/VPAC2 Expression by Sitagliptin in Non-Diabetic Rat Model of Hepatic Ischemia-Reperfusion Injury.
Krzystek-Korpacka M; Fleszar MG; Fortuna P; Gostomska-Pampuch K; Lewandowski Ł; Piasecki T; Kosyk B; Szeląg A; Trocha M
Int J Mol Sci; 2021 Dec; 22(23):. PubMed ID: 34884960
[TBL] [Abstract][Full Text] [Related]
11. Novel repair mechanisms in a renal ischaemia/reperfusion model: Subsequent saxagliptin treatment modulates the pro-angiogenic GLP-1/cAMP/VEGF, ANP/eNOS/NO, SDF-1α/CXCR4, and Kim-1/STAT3/HIF-1α/VEGF/eNOS pathways.
Kamel NM; Abd El Fattah MA; El-Abhar HS; Abdallah DM
Eur J Pharmacol; 2019 Oct; 861():172620. PubMed ID: 31437429
[TBL] [Abstract][Full Text] [Related]
12. (Pro)renin receptor mediates tubular epithelial cell pyroptosis in diabetic kidney disease via DPP4-JNK pathway.
Xie S; Song S; Liu S; Li Q; Zou W; Ke J; Wang C
J Transl Med; 2024 Jan; 22(1):26. PubMed ID: 38183100
[TBL] [Abstract][Full Text] [Related]
13. Head-to-head comparison of structurally unrelated dipeptidyl peptidase 4 inhibitors in the setting of renal ischemia reperfusion injury.
Reichetzeder C; von Websky K; Tsuprykov O; Mohagheghi Samarin A; Falke LG; Dwi Putra SE; Hasan AA; Antonenko V; Curato C; Rippmann J; Klein T; Hocher B
Br J Pharmacol; 2017 Jul; 174(14):2273-2286. PubMed ID: 28423178
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic strategies utilizing SDF-1α in ischaemic cardiomyopathy.
Ziff OJ; Bromage DI; Yellon DM; Davidson SM
Cardiovasc Res; 2018 Mar; 114(3):358-367. PubMed ID: 29040423
[TBL] [Abstract][Full Text] [Related]
15. Huangkui capsule attenuates diabetic kidney disease through the induction of mitophagy mediated by STING1/PINK1 signaling in tubular cells.
Zhu Z; Luan G; Peng S; Fang Y; Fang Q; Shen S; Wu K; Qian S; Jia W; Ye J; Wei L
Phytomedicine; 2023 Oct; 119():154975. PubMed ID: 37517171
[TBL] [Abstract][Full Text] [Related]
16. Disruption of renal tubular mitochondrial quality control by Myo-inositol oxygenase in diabetic kidney disease.
Zhan M; Usman IM; Sun L; Kanwar YS
J Am Soc Nephrol; 2015 Jun; 26(6):1304-21. PubMed ID: 25270067
[TBL] [Abstract][Full Text] [Related]
17. SDF-1α (Stromal Cell-Derived Factor 1α) Induces Cardiac Fibroblasts, Renal Microvascular Smooth Muscle Cells, and Glomerular Mesangial Cells to Proliferate, Cause Hypertrophy, and Produce Collagen.
Jackson EK; Zhang Y; Gillespie DD; Zhu X; Cheng D; Jackson TC
J Am Heart Assoc; 2017 Nov; 6(11):. PubMed ID: 29114002
[TBL] [Abstract][Full Text] [Related]
18. Urinary DPP4 correlates with renal dysfunction, and DPP4 inhibition protects against the reduction in megalin and podocin expression in experimental CKD.
Benetti A; Martins FL; Sene LB; Shimizu MHM; Seguro AC; Luchi WM; Girardi ACC
Am J Physiol Renal Physiol; 2021 Mar; 320(3):F285-F296. PubMed ID: 33346727
[TBL] [Abstract][Full Text] [Related]
19. Empagliflozin improves diabetic renal tubular injury by alleviating mitochondrial fission via AMPK/SP1/PGAM5 pathway.
Liu X; Xu C; Xu L; Li X; Sun H; Xue M; Li T; Yu X; Sun B; Chen L
Metabolism; 2020 Oct; 111():154334. PubMed ID: 32777444
[TBL] [Abstract][Full Text] [Related]
20. DPP-4 inhibition has beneficial effects on the heart after myocardial infarction.
Kubota A; Takano H; Wang H; Hasegawa H; Tadokoro H; Hirose M; Kobara Y; Yamada-Inagawa T; Komuro I; Kobayashi Y
J Mol Cell Cardiol; 2016 Feb; 91():72-80. PubMed ID: 26739213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
